S599 | Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs | Smith & Moses
Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs
2023-2024 SessionJulia SalazarAffects: Insurance Law
Status
✓ Signed Into Law
Impact Rating
Unable to calculate
Passage Likelihood
Passed ✓
Bill Progress
✓
Introduced
✓
In Committee
✓
Committee Passed
✓
Floor Calendar
✓
Passed Chamber
✓
Other Chamber
✓
Introduced
✓
In Committee
✓
Committee Passed
✓
Floor Calendar
✓
Passed Chamber
✓
Other Chamber
What's Happening
Why It Matters
Waiting for summary...
Get alerts when S599 moves
Create a free account to track this bill and get emailed when its status changes — committee votes, floor action, signing, or veto.